Synektik S.A. Logo

Synektik S.A.

Manufactures radiopharma; provides medical equipment, IT solutions, and services to specialists.

SNT | WAR

Overview

Corporate Details

ISIN(s):
PLSNKTK00019
LEI:
259400U0O19JWLVHQN14
Country:
Poland
Address:
WARSZAWA JÓZEFA PIUSA DZIEKOŃSKIEGO 3, 00-728 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Synektik S.A. is a provider and integrator of innovative solutions for the medical sector, with a focus on radiology, oncology, cardiology, and neurology. The company's core operations include the manufacturing of radiopharmaceuticals, the supply and service of advanced medical equipment, and the development of specialized IT solutions. Synektik supports medical facilities with products and services used in diagnostic imaging, nuclear medicine, and surgery, aiming to implement and disseminate modern medical technologies. The company also provides comprehensive maintenance for medical devices and IT infrastructure.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-18 08:39
Regulatory News Service
Śródroczne skrócone skonsolidowane sprawozdanie finansowe za 4 kw. 2024
Polish 1.3 MB
2025-11-18 08:39
Regulatory News Service
wybrane dane finansowe za 4 kw. 2024
Polish 204.6 KB
2025-10-28 09:40
Report Publication Announcement
Terminy publikacji raportów okresowych - Content (PL)
Polish 2.0 KB
2025-10-27 15:29
Major Shareholding Notification
Zawiadomienie
Polish 83.0 KB
2025-10-27 15:29
Major Shareholding Notification
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie publicznej - zmiana …
Polish 1.7 KB
2025-10-27 12:52
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-23 12:37
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-21 08:51
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-20 10:43
Regulatory News Service
Temat: Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - C…
Polish 1.8 KB
2025-10-14 14:39
Related Party Transaction
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 1.3 KB
2025-10-09 09:16
Regulatory News Service
Wybrane dane operacyjne segmentu sprzedaży sprzętu, rozwiązań IT oraz usług - C…
Polish 1.4 KB
2025-09-29 13:34
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.7 KB
2025-09-23 14:05
Board/Management Information
życiorys nowego Członka Zarządu
Polish 92.3 KB
2025-09-23 14:05
Board/Management Information
Powołanie nowego Członka Zarządu - Content (PL)
Polish 1.2 KB
2025-09-16 16:47
Related Party Transaction
Uzupełnienie informacji o zawarciu istotnej umowy sprzedaży systemu robotyczneg…
Polish 1.3 KB

Automate Your Workflow. Get a real-time feed of all Synektik S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Synektik S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Synektik S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland
PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland
PPGN
PolyPid Ltd. Logo
Develops localized, prolonged-release drug therapies for surgery, oncology & metabolic diseases.
United States of America
PYPD
Praxis Precision Medicines, Inc. Logo
Developing therapies for CNS disorders using insights from genetic epilepsies.
United States of America
PRAX
PRECIGEN, INC. Logo
Develops gene and cell therapies for difficult-to-treat diseases using precision technology.
United States of America
PGEN
Precipio, Inc. Logo
Provides blood cancer diagnostic services & products to improve accuracy for physicians & labs.
United States of America
PRPO
PRECISION BIOSCIENCES INC Logo
A clinical-stage company using ARCUS gene editing to treat cancer and rare genetic diseases.
United States of America
DTIL
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea
335810
Prelude Therapeutics Inc Logo
Clinical-stage oncology company developing novel protein degraders and ADCs for cancer.
United States of America
PRLD
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea
334970

Talk to a Data Expert

Have a question? We'll get back to you promptly.